Inventor · disambiguated record
Anandan Palani
Also filed as: PALANI ANANDAN
70 granted patents·38 pending applications·626 citations·filing 2000–2024
99Inventor score
Files withSCHERING CORP28MERCK SHARP & DOHME16MERCK SHARP & DOHME LLC13OPKO HEALTH INC9HUANG XIANHAI7
Top patents by PatentIndex Score
108 records- 0197US6689765B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2002·Granted Feb 10, 2004·71 cites·12 claims
- 0297US6391865B1Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2000·Granted May 21, 2002·94 cites·19 claims
- 0395US6387930B1Piperidine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2000·Granted May 14, 2002·76 cites·13 claims
- 0494US7884080B2Azetidinone derivatives and methods of use thereofSCHERING PLOUGH CORP·Filed 2007·Granted Feb 8, 2011·46 cites·23 claims
- 0594US7049320B2NK1 antagonistsSCHERING CORP·Filed 2002·Granted May 23, 2006·54 cites·17 claims
- 0693US11697657B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 11, 2023·4 cites·22 claims
- 0792US7902366B2NK1 antagonistsOPKO HEALTH INC·Filed 2006·Granted Mar 8, 2011·19 cites·19 claims
- 0892US7709641B2NK1 antagonistsOPKO HEALTH INC·Filed 2005·Granted May 4, 2010·20 cites·30 claims
- 0991US9364482B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Jun 14, 2016·8 cites·15 claims
- 1090US9243002B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CMERCK SHARP & DOHME·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 1189US8026364B2NK1 antagonistsOPKO HEALTH INC·Filed 2010·Granted Sep 27, 2011·11 cites·39 claims
- 1288US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 1388US8796299B2NK1 antagonistsOPKO HEALTH INC·Filed 2012·Granted Aug 5, 2014·9 cites·15 claims
- 1487US10493125B2Co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 3, 2019·4 cites·20 claims
- 1587US8273895B2NK1 antagonistsPALIWAL SUNIL·Filed 2010·Granted Sep 25, 2012·12 cites·3 claims
- 1685US7045636B2MCH antagonists for the treatment of obesitySCHERING CORP·Filed 2002·Granted May 16, 2006·35 cites·21 claims
- 1785US6602885B2Piperidine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2001·Granted Aug 5, 2003·21 cites·17 claims
- 1884US11492385B2Long-acting co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2020·Granted Nov 8, 2022·1 cites·33 claims
- 1984US10793615B2Long-acting co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2016·Granted Oct 6, 2020·4 cites·17 claims
- 2084US8754216B2NK1 antagonistsSHAH SAPNA S·Filed 2011·Granted Jun 17, 2014·9 cites·38 claims
- 2184US6900329B2MCH antagonists and their use in the treatment of obesitySCHERING CORP·Filed 2002·Granted May 31, 2005·18 cites·17 claims
- 2283US8450343B2Gamma secretase modulatorsHUANG XIANHAI·Filed 2008·Granted May 28, 2013·9 cites·8 claims
- 2383US7763623B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2007·Granted Jul 27, 2010·9 cites·39 claims
- 2482US9242998B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 2581US12297208B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 2681US12291538B2Small molecule inhibitors of KRAS G12C mutantMERCK SHARP & DOHME LLC·Filed 2023·Granted May 6, 2025·0 cites·6 claims
- 2780US9573939B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 21, 2017·6 cites·6 claims
- 2880US8426595B2Gamma secretase modulatorsHUANG XIANHAI·Filed 2008·Granted Apr 23, 2013·4 cites·8 claims
- 2979US7723342B2Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemiaSCHERING CORP·Filed 2006·Granted May 25, 2010·4 cites·61 claims
- 3079US7354922B2Bridged ring NK1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 8, 2008·4 cites·30 claims
- 3178US9469629B2NK1 antagonistsOPKO HEALTH INC·Filed 2014·Granted Oct 18, 2016·2 cites·12 claims
- 3278US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 3378US8592383B2Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulatorsHUANG XIANHAI·Filed 2012·Granted Nov 26, 2013·5 cites·48 claims
- 3478US8518975B2Gamma secretase modulatorsASLANIAN ROBERT G·Filed 2008·Granted Aug 27, 2013·5 cites·15 claims
- 3578US7737155B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2007·Granted Jun 15, 2010·2 cites·35 claims
- 3678US7384944B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2003·Granted Jun 10, 2008·6 cites·18 claims
- 3776US10413593B2Co-agonists of the glucagon and GLP-1 receptorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 17, 2019·2 cites·30 claims
- 3876US8426403B2Gamma secretase modulatorsZHU ZHAONING·Filed 2008·Granted Apr 23, 2013·2 cites·9 claims
- 3974US8673900B2Gamma secretase modulatorsZHU ZHAONING·Filed 2009·Granted Mar 18, 2014·2 cites·2 claims
- 4074US7750015B2Nitrogen-containing heterocyclic compounds and methods of use thereofSCHERING CORP·Filed 2006·Granted Jul 6, 2010·2 cites·47 claims
- 4172US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 4272US7384948B2Piperidine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2003·Granted Jun 10, 2008·4 cites·6 claims
- 4370US8357682B2Gamma secretase modulatorsZHU ZHAONING·Filed 2008·Granted Jan 22, 2013·1 cites·37 claims
- 4470US2025326766A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 4570US2024025912A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 4668US7442703B2Piperidine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2003·Granted Oct 28, 2008·2 cites·10 claims
- 4767US9549917B2Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Jan 24, 2017·1 cites·14 claims
- 4866US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 4965US8283360B2Bicyclic heterocyclic derivatives and methods of use thereofPALANI ANANDAN·Filed 2009·Granted Oct 9, 2012·1 cites·2 claims
- 5065US8114879B2Piperazine derivatives useful as CCR5 antagonistsBAROUDY BAHIGE M·Filed 2008·Granted Feb 14, 2012·0 cites·14 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anandan Palani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →